DTx Pharma mentioned by JNJ executive as one of the world’s 20 hottest startups following JLABs portfolio showcase

//DTx Pharma mentioned by JNJ executive as one of the world’s 20 hottest startups following JLABs portfolio showcase

DTx Pharma mentioned by JNJ executive as one of the world’s 20 hottest startups following JLABs portfolio showcase

DTx Pharma, a RNA-based therapeutics company, announced that it was one of 3 companies chosen from the JLABs San Diego site to present a 3-minute pitch to a global audience of investors, executives, physicians, strategic investors and government partners located in New York, San Francisco, Boston, Toronto, Houston and San Diego.  Following the presentation, DTx was featured in a note and photograph by Arjun Desai, Vice President of Innovation at Johnson & Johnson, “as one of the 20 hottest startups in the world”.

By | 2018-02-27T18:22:36+00:00 November 29th, 2017|Uncategorized|0 Comments